Goodwin (JD Supra Denmark)

1 result for Goodwin (JD Supra Denmark)

  • Results of Danish Infliximab Biosimilar Switching Study Published

    Researchers in Denmark recently published a report from an observational study of 802 Danish patients who switched from Remicade to the biosimilar infliximab product Remsima for the treatment of rheumatoid arthritis, psoriatic arthritis, and axial spondyloarthritis. In May 2015, Denmark implemented a national guideline mandating non-medical switching of all patients treated with Remicade to...

  • Request a trial to view additional results

VLEX uses login cookies to provide you with a better browsing experience. If you click on 'Accept' or continue browsing this site we consider that you accept our cookie policy. ACCEPT